Value20202021202220232024TTMCash from investing activities42.88 M524.41 M26.95 M116.78 M350.44 M350.44 MCash from financing activities14.8 M586 K546.05 M628.81 M969.59 M969.59 MFree cash flow336.58 M334.91 M292.86 M671.54 M875.84 M875.84 M
Exelixis Inc
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.